eClinical Solutions

eClinical Solutions’ mission is to make clinical research data acquisition and analysis easy and intelligent to help bring new treatments to patients faster.

[eClinical Solutions @eClinical_Sol]

Without the right foundation, moonshot automation carries a higher risk of failure, delayed value, and lost opportunity. The pragmatic path forward lies in what is deployable and defensible today, shares eClinical's @vmallarapu.

Venu connected with @pharmasalmanac to explain how companies can distinguish between “moonshot” automation and validated digital tools that can be deployed today.

Read here: https://t.co/Lqfy3DN7ze

[eClinical Solutions @eClinical_Sol]

How are tools like AI-driven central monitoring or real time RBQM changing what's possible in clinical oversight?

eClinical's Vera Pomerantseva recently joined @Certara's Oxana Iliach and @JsmithParker, host of @BioSpace's Denatured podcast, to answer this question and more.

Listen to the full episode here, where they discuss the @US_FDA's one pivotal trial policy, risk management, and AI's role in uncovering new therapies: https://t.co/IkLVrqWDby

[eClinical Solutions @eClinical_Sol]

🎉 We're proud to share that Nathan Johnson has been appointed Chief Product Officer of eClinical Solutions:

In his role Nathan leads product strategy and roadmap, ensuring our solutions remain innovative and outcomes-focused to meet the demands of the AI era.

Under Nathan's direction, the elluminate Clinical Data Intelligence Platform continuously evolves its next-gen capabilities to meet industry demands, provide tangible value, and accelerate research.

Congratulations Nathan, and thank you for your visionary product leadership!

[eClinical Solutions @eClinical_Sol]

📣eClinical and Hobson & Company have announced the results of their collaboration to determine the ROI of the elluminate® Clinical Data Intelligence Platform.

Findings include:

🔹 90% reduction in time spent on data aggregation from multiple disparate systems
🔹 30% less time spent gathering data for monitoring trial progress/oversight
🔹25% reduction in cycle time from last patient last visit (LPLV) to database lock
🔹And more.

In addition, eClinical has launched ROI calculators for both pharmaceutical companies and CROs to bring price transparency to clinical trial technology investment and return.

Learn how the elluminate platform demonstrates tangible ROI in an era where cycle times and efficiency are key factors in clinical research: https://t.co/vIakJCbzVh

[eClinical Solutions @eClinical_Sol]

Today's clinical trials generate more data than ever before — and while technology is keeping up, people and processes may not evolve fast enough.

eClinical's Katrina Rice recently explained how she led eClinical's Biometrics Services team to evolve through deliberate, disciplined shifts in mindset, process, and evaluation.

Discover how she transformed her team's use of technology here: https://t.co/nD1ijWQD40

[eClinical Solutions @eClinical_Sol]

Technological advances in analytics, data integration, and centralized oversight have made RBQM as identified in ICH E6(R3) possible. But not all approaches will support these new regulatory expectations equally.

Our latest blog examines three common types of RBQM technology and compares how effectively each supports the full RBQM lifecycle:

✦ Point solutions
✦ Traditional clinical systems
✦ Integrated RBQM platforms

Looking to meet ICH E6(R3) expectations and operationalize RBQM across the full trial lifecycle? Don't miss this guide: https://t.co/LC8GOWUebA

[eClinical Solutions @eClinical_Sol]

When the FDA recently shifted toward a single trial paradigm for drug approvals, sponsors faced increased pressure to strengthen evidence before regulatory submission.

Now, sponsors are rethinking trial design to provide risk-based data review and quality management for oversight of the entire portfolio and mitigate risk across the trial life cycle.

eClinical's Vera Pomerantseva explains how #RBQM and embedded #AI are providing operational value amid new regulatory frameworks in Pharma's Almanac: https://t.co/xomUpTLMVV

[eClinical Solutions @eClinical_Sol]

The @EverestGroup 2025 Tech Provider Spotlight: RBQM outlines several trends shaping the RBQM landscape, including the integration of AI and predictive analytics, the digitization of oversight, regulatory acceleration, and the convergence of RBQM with clinical data management.

Our latest blog explores highlights from the Everest Group Tech Provider Spotlight and what they may mean for your organization.

Read it here: https://t.co/oOn1tvtup1

[eClinical Solutions @eClinical_Sol]

Is your organization ready for AI?

The organizations leading AI-driven clinical development don't have the biggest budgets — they're the ones doing the architectural groundwork, says eClinical's @vmallarapu.

Venu shares five questions to ensure your AI investment is a success in our latest blog: https://t.co/ELSxjZbbRW

[eClinical Solutions @eClinical_Sol]

RBQM has been a regulatory expectation for over a decade, yet many organizations still struggle to operationalize it consistently and at scale.

On April 7, join eClinical and @ZSAssociates' Jonathan Rowe for an in-person educational discussion on how to move from reactive risk management to proactive, integrated quality leadership.

Space is limited, so register today! https://t.co/T8pKhCVZM3

[eClinical Solutions @eClinical_Sol]

Hear eClinical's Vera Pomerantseva discuss how the FDA's shift to a single pivotal trial for drug approvals fundamentally changes the risk calculus for sponsors in a new interview with @PharmExec.

Check out the full conversation here: https://t.co/EQP5jcAt4h

[eClinical Solutions @eClinical_Sol]

NEW 📣 We're proud to share that @argenxglobal SE is expanding adoption of the elluminate Clinical Data Cloud® to improve and enhance clinical data processes.

“We’re excited to continue supporting argenx’s commitment to future-proofing clinical trials with a modern data infrastructure,” said eClinical CEO @Raj_Indupuri.

Learn more about how this innovation allows for real-time data and operational insights to advance argenx's immunology breakthroughs: https://t.co/QBmD1bxGt0

[eClinical Solutions @eClinical_Sol]

Attending #PHUSE US Connect this week? Don't miss these presentations from our experts! 👇

"DH06: Reimagining SDTM Mapping with Agentic AI and Automation" with Nathan Johnson
🗓️ Tuesday, March 24
🕒 2:30-3PM

"RM02: Operationalising ICH E6 R3: A Risk-Based Blueprint for Data Management" with Vera Pomerantseva
🗓️ Thursday, March 26
🕒 11:30-12PM

Visit us at Booth # 6 to learn how to modernize and automate your digital data flow for more efficient clinical trials.

Learn more: https://t.co/SnsuHlVPMn

@PHUSE_Global

[eClinical Solutions @eClinical_Sol]

The AI imperative is clear: without it, the pharma industry risks being overwhelmed by its own data, shares @Raj_Indupuri.

eClinical's CEO explains why AI is reshaping clinical development and how industry leaders can balance innovation with oversight.

Read in @PharmExec: https://t.co/umvPSemsVf

[eClinical Solutions @eClinical_Sol]

🤝 Announcing two new additions to our C-Suite...
Lauren Whitsell (Fuchs) as Chief Operating Officer and @vmallarapu as Chief Transformation and AI Officer.

With over two decades of experience across technology and healthcare and a proven track record of operational leadership, Lauren will focus on all post-sale business functions while championing a culture of high-quality customer service and operational excellence across the company.

In his new role, Venu will drive eClinical's AI-first strategy, ensuring technology and processes optimize AI and automation to support workforce transformation and deliver exceptional customer experience.

Learn more about how these appointees support eClinical's long-term strategic pillars amid rapid growth and scaling operations: https://t.co/ZZM1WJgDNS

[eClinical Solutions @eClinical_Sol]

#ICYMI 🔔 We recently celebrated a few milestones — eClinical's portfolio of biopharma and CRO clients now includes 18 of the top 50 global pharmaceutical companies, and we're doubling down on agentic AI and RBQM investments to bend the clinical development efficiency curve.

We also unveiled new elluminate platform updates that support sponsor objectives, from ensuring ease of compliance with ICH E6 R(3) to expanding agentic AI efficiencies:

🔹 Agentic data review automation
🔹 End-to-end RBQM traceability
🔹 Faster, more consistent RBQM setup
🔹 Guided centralized monitoring experience
🔹 Agentic SDTM mapping automation from spec to executable code

Catch up on all the updates here: https://t.co/HY2HOvq5Cn

[eClinical Solutions @eClinical_Sol]

📣 We are thrilled to announce updates to the elluminate platform to ensure ease of compliance for sponsors with the revised ICH E6 R(3) guidelines and expanded agentic AI efficiencies.

These updates build on momentum from our 2025 highlights, including the launch of elluminate AI agents, collaboration with @ZSAssociates, recognition from @EverestGroup, @SCDM, @TopWorkplaces, and more.

More details on this news: https://t.co/HY2HOvq5Cn

[eClinical Solutions @eClinical_Sol]

2025 saw major impacts in life science that reshaped how therapies are discovered, developed, and delivered, while also introducing new risks around compliance, data, and cybersecurity.

eClinical's Vera Pomerantseva and Katrina Rice connected with @healthitanswers to share their thoughts on how the industry will build on this momentum in 2026: https://t.co/mGzTiM4gt4

[eClinical Solutions @eClinical_Sol]

Over the next decade, #biopharma will be reshaped less by a single breakthrough and more by how intelligence is applied across the clinical and development life cycle.

eClinical's Venu Mallarapu explains why the rise of collaborative, domain-aware #AI agents will redefine how biopharma organizations operate in @PharmasAlmanac: https://t.co/IUbi5cQsQg

[eClinical Solutions @eClinical_Sol]

🏆 We are proud to share that @EverestGroup has recognized eClinical Solutions in its Tech Provider Spotlight for Risk-Based Quality Management (RBQM)!

The report highlighted eClinical's strong market adoption and client base, comprehensive platform capabilities, technology maturity and stability, and thought leadership and market impact.

Access the report here: https://t.co/OOctnSTj9Y